SS
HAE icon

SBI Securities’s Haemonetics HAE Stock Holding History

SBI Securities’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$525 Hold
7
– – ﹤0.01% 3020
2026
Q1 		$395 Hold
7
– – ﹤0.01% 2978
2025
Q4 		$561 Sell
7
-1
-13% -$67 ﹤0.01% 2830
2025
Q3 		$390 Buy
8
+1
+14% +$62 ﹤0.01% 3073
2025
Q2 		$522 Buy
7
+1
+17% +$66 ﹤0.01% 2944
2025
Q1 		$381 Sell
6
-10
-63% -$680 ﹤0.01% 2974
2024
Q4 		$1.25K Buy
+16
New +$1.28K ﹤0.01% 2505

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SBI Securities's HAE Position: Q2 2026 in Review

SBI Securities held its Haemonetics (HAE) position steady in Q2 2026 at 7 shares worth $525. The position accounts for ﹤0.01% of the portfolio, ranked #3020.

SBI Securities first reported a position in HAE in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.25K in Q4 2024. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • SBI Securities held 7 shares of Haemonetics worth $525 as of Q2 2026.
  • SBI Securities left its Haemonetics share count unchanged in Q2 2026.
  • Haemonetics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3020 holding.
  • SBI Securities first reported a position in Haemonetics in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Haemonetics position peaked at $1.25K in Q4 2024.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.